FOXH1

(redirected from FAST1)

FOXH1

A gene on chromosome 8q24.3 that encodes a member of the forkhead family of transcription factors, which activates an activin response element.
References in periodicals archive ?
The global intraosseous infusion devices market is segmented on the basis of Product Type (B.I.G (Bone Injection Gun), FAST1, EZ-IO, FAST Responder, Intraosseous Needles, Others); Technology (Manual, Automatic); End User (Emergency Medical Services, Hospitals, Ambulatory Surgical Centres, Cardiac Care Centres); Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus); and Region (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa).
R22, R16, and R33 are identified by FAST1 method as greatly important reactions.
In order to validate sensitivity indices measured by FAST1 and FAST2 methods, the profiles of sensitivity indices for the FAST1 and Sobol' methods are compared.
However, Sobol' method and FAST1 method regard R22 as a very important factor contributing to output temperature, which means variance-based GSA methods may not be a good tool to diagnose this system.
R69 has little impact on the temperature estimated by the FAST1 method.
[15] shows the presence of increased amounts of a novel transcript FAST1 (FXN antisense transcript-1) in FRDA patients which may prove tobe significant.
(the "Company") announced the completion of the manufacturing transfer of its highest volume product, FAST1, to Donatelle Plastics, Inc.
Intraosseous access has been modernized and simplified through the introduction of devices such as the Bone Injection Gun (Waismed Ltd, Herzliya, Israel), the FAST1 (Pyng Medical Corporation, Richmond, British Columbia, Canada), and the Vidacare EZ-IO (Figures 4 and 5).
Asimismo, se han encontrado mutaciones en 9 genes como causantes de HPE: SHH, PTCH, GLI2, DHCR7, ZIC2, TDGF1, TGIF, FAST1 y SIX3.
Market segmentation The global intraosseous infusion devices market is segmented on the basis of Product Type (B.I.G (Bone Injection Gun), FAST1, EZ-IO, FAST Responder, Intraosseous Needles, Others); Technology (Manual, Automatic); End User (Emergency Medical Services, Hospitals, Ambulatory Surgical Centres, Cardiac Care Centres); Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus); and Region (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa).